You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 53 No. 12, December 1996 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL ARTICLES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (203)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Childhood-Onset Schizophrenia

A Double-blind Clozapine-Haloperidol Comparison

Sanjiv Kumra, MD; Jean A. Frazier, MD; Leslie K. Jacobsen, MD; Kathleen McKenna, MD; Charles T. Gordon, MD; Marge C. Lenane, MSW; Susan D. Hamburger, MA, MS; Amy K. Smith; Kathleen E. Albus; Javad Alaghband-Rad, MD; Judith L. Rapoport, MD

Arch Gen Psychiatry. 1996;53(12):1090-1097.


Abstract



Background
Childhood-onset schizophrenia is a rare but severe form of the disorder that is often treatmentrefractory. In this study, the efficacy and adverse effects of clozapine and haloperidol were compared for children and adolescents with early-onset schizophrenia.

Methods
Twenty-one patients (mean [±SD] age, 14.0 ±2.3 years) with onset of Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition— defined schizophrenia that began by age 12 years and who had been nonresponsive to typical neuroleptics participated in the study. Patients were randomized to a 6-week double-blind parallel comparison of clozapine (mean [ ±SD] final dose, 176± 149 mg/d), or haloperidol, (16±8 mg/d).

Results
Clozapine was superior to haloperidol on all measures of psychosis (P=.04-.002). Positive and negative symptoms of schizophrenia improved. However, neutropenia and seizures were major concerns. To date, one third of the group has discontinued using clozapine.

Conclusions
Clozapine has striking superiority for positive and negative symptoms in treatment-refractory childhood-onset schizophrenia. However, due to possibly increased toxic effects in this pediatric population, close monitoring for adverse events is essential.



Author Affiliations



From the Child Psychiatry Branch, National Institute of Mental Health, Bethesda, Md (Drs Kumra, Jacobsen, Alaghband-Rad, and Rapoport and Mss Lenane, Hamburger, Smith, and Albus); Harvard University School of Medicine, Boston, Mass (Dr Frazier); Northwestern University School of Medicine, Chicago, Ill (Dr McKenna); and University of Maryland School of Medicine, Baltimore (Dr Gordon).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Lack of Gender Influence on Cortical and Subcortical Gray Matter Development in Childhood-Onset Schizophrenia
Weisinger et al.
Schizophr Bull 2011;0:sbr049v4-sbr049.
ABSTRACT | FULL TEXT  

Comparative Effectiveness of Second-Generation Antipsychotic Medications in Early-Onset Schizophrenia
Olfson et al.
Schizophr Bull 2011;0:sbq172v1-sbq172.
ABSTRACT | FULL TEXT  

Prescribing antipsychotics for children and adolescents
James
Adv. Psychiatr. Treat. 2010;16:63-75.
ABSTRACT | FULL TEXT  

Efficacy and Tolerability of Second-Generation Antipsychotics in Children and Adolescents With Schizophrenia
Kumra et al.
Schizophr Bull 2008;34:60-71.
ABSTRACT | FULL TEXT  

Cortical Brain Development in Nonpsychotic Siblings of Patients With Childhood-Onset Schizophrenia
Gogtay et al.
Arch Gen Psychiatry 2007;64:772-780.
ABSTRACT | FULL TEXT  

Childhood-Onset Schizophrenia: A Double-Blind, Randomized Clozapine-Olanzapine Comparison.
Shaw et al.
Arch Gen Psychiatry 2006;63:721-730.
ABSTRACT | FULL TEXT  

National trends in the outpatient treatment of children and adolescents with antipsychotic drugs.
Olfson et al.
Arch Gen Psychiatry 2006;63:679-685.
ABSTRACT | FULL TEXT  

Clozapine prescribing in adolescent psychiatry: survey of prescribing practice in in-patient units
Cirulli
The Psychiatrist 2005;29:377-380.
ABSTRACT | FULL TEXT  

Metabolic side effects of atypical antipsychotics in children: a literature review
Fedorowicz and Fombonne
J Psychopharmacol 2005;19:533-550.
ABSTRACT  

Prevalence of Atypical Antipsychotic Drug Use Among Commercially Insured Youths in the United States
Curtis et al.
Arch Pediatr Adolesc Med 2005;159:362-366.
ABSTRACT | FULL TEXT  

Incidences of New Prescribing by British Child and Adolescent Psychiatrists: a Prospective Study Over 12 Months
Clark
J Psychopharmacol 2004;18:115-120.
ABSTRACT  

Comparison of Progressive Cortical Gray Matter Loss in Childhood-Onset Schizophrenia With That in Childhood-Onset Atypical Psychoses
Gogtay et al.
Arch Gen Psychiatry 2004;61:17-22.
ABSTRACT | FULL TEXT  

Clozapine v. conventional antipsychotic drugs for treatment-resistant schizophrenia: a re-examination
MONCRIEFF
Br. J. Psychiatry 2003;183:161-166.
ABSTRACT | FULL TEXT  

Current issues in child and adolescent psychopharmacology. Part 2: Anxiety and obsessive-compulsive disorders, autism, Tourette's and schizophrenia
Coghill
Adv. Psychiatr. Treat. 2003;9:289-299.
ABSTRACT | FULL TEXT  

A Meta-analysis of the Efficacy of Second-Generation Antipsychotics
Davis et al.
Arch Gen Psychiatry 2003;60:553-564.
ABSTRACT | FULL TEXT  

Psychopharmacology and Aggression: II. A Meta-Analysis of Nonstimulant Medication Effects on Overt Aggression-Related Behaviors in Youth with SED
Connor et al.
Journal of Emotional and Behavioral Disorders 2003;11:157-168.
ABSTRACT  

Proposed treatment for adolescent psychosis. 1: Schizophrenia and schizophrenia-like psychoses
Clark
Adv. Psychiatr. Treat. 2001;7:16-23.
FULL TEXT  

Clozapine in Childhood-Onset Schizophrenia: A Report of Five Cases
Malhotra et al.
Clin Child Psychol Psychiatry 2000;5:403-410.
ABSTRACT  

Refractory schizophrenia and atypical antipsychotics
Taylor et al.
J Psychopharmacol 2000;14:409-418.
ABSTRACT  

Adolescent schizophrenia
Hollis
Adv. Psychiatr. Treat. 2000;6:83-92.
FULL TEXT  

Progressive Cortical Change During Adolescence in Childhood-Onset Schizophrenia: A Longitudinal Magnetic Resonance Imaging Study
Rapoport et al.
Arch Gen Psychiatry 1999;56:649-654.
ABSTRACT | FULL TEXT  

Childhood-Onset Schizophrenia
Bhatara et al.
Arch Gen Psychiatry 1998;55:90-92.
FULL TEXT  

Childhood-Onset Schizophrenia: Progressive Ventricular Change During Adolescence
Rapoport et al.
Arch Gen Psychiatry 1997;54:897-903.
ABSTRACT  

Autonomic Nervous System Markers of Psychopathology in Childhood-Onset Schizophrenia
Zahn et al.
Arch Gen Psychiatry 1997;54:904-912.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.